天美传媒

Dr. Inderpal Randhawa is a leading specialist with board certifications in allergy, immunology, pulmonology, general pediatrics, and internal medicine. He gained interest in food allergy while serving as a sub-investigator in an early study utilizing Omalizumab (Trade name: Xolair). Meanwhile, he was witnessing a dramatic and unprecedented increase in the number of pediatric patients admitted to the intensive care unit as the result of anaphylaxis. The severity and frequency of these cases drove Dr. Randhawa to question the direction of food allergy treatment and motivated him to find more effective solutions than those from clinical trials.

In addition, Dr. Randhawa had experience desensitizing lung transplant patients with life-threatening allergies to critical and indispensable anti-rejection drugs that utilized a patient-specific desensitization protocol. These experiences, and his collaboration with national allergy and immunology specialists, informed Dr. Randhawa鈥檚 precision medicine approach to treating food allergy. Since 2005, he has successfully treated more than 2,000 patients with life-threatening allergies to peanut, tree nuts, milk, egg, wheat, soy, seafood, seeds, and other foods using his unique, research-based Tolerance Induction Program, achieving an unmatched 99% rate of success.

Dr. Randhawa serves as the program director and research coordinator in two fellowship programs at the David Geffen UCLA School of Medicine and UC Irvine 鈥� Miller Children鈥檚 Hospital. In addition, he practices clinical medicine in pulmonary diseases, immune deficiencies, allergy and transplant medicine. Dr. Randhawa is also the Founder and Medical Director of the Translational Pulmonary and Immunology Research Center (TPIRC).

Dr. Randhawa received his medical degree from Northwestern University鈥檚 Feinberg School of Medicine. After completing a combined internal medicine/pediatrics residency, he completed training in Clinical Immunology & Allergy at UCLA and pediatric and adult pulmonology at UC Irvine 鈥� Miller Children鈥檚 Hospital. Dr. Randhawa has authored over 150 peer reviewed abstracts and research publications and has served as primary investigator in over 25 clinical trials.

Benjamin J. Seides, MD, MPH, director of interventional pulmonology at Northwestern Medicine Central DuPage Hospital.
Dr. Seides is a board-certified interventional pulmonologist with training and additional American Board of Internal Medicine certification in internal medicine, pulmonary and critical care medicine. His clinical interests include minimally invasive advanced diagnostic and therapeutic approaches to benign and malignant diseases of the lung, pleura and thorax; complex airway disease; thoracic oncology; and endobronchial treatments for asthma and COPD. Dr. Seides earned his medical degree from Tulane University School of Medicine, where he was elected to AOA, and he earned a Master of Public Health in health systems management from Tulane University School of Public Health and Tropical Medicine in New Orleans. He completed his residency in internal medicine, as well as his fellowship in pulmonary and critical care medicine, at New York University/Bellevue Hospital Centers. He went on to complete an advanced fellowship year in interventional pulmonology with the Chicago Chest Center.

, is a board-certified pulmonologist who treats patients with a variety of respiratory conditions. His interests include pulmonary vascular disease, critical care medicine, and pulmonary vascular malformations such hereditary hemorrhagic telangiectasia (a disorder that affects blood vessels).
He has treated many patients with COVID-19 and led efforts to assist health care professionals in Tijuana during the pandemic.
Mandel is the Kenneth M. Moser Professor of Medicine at the UC San Diego School of Medicine and chief of the Pulmonary, Critical Care and Sleep Medicine Division and serves as vice chair for education in the Department of Internal Medicine.
Mandel was honored with a Presidential Citation by the San Diego County Medical Society for his involvement in their COVID response. More significantly, he helped organize relief efforts in Tijuana and Mexicali, reducing the cross-border spread of COVID and saving hundreds of lives.
He is active in several leadership roles with the American Thoracic Society, including serving as chair of their international conference.

, is a board-certified pulmonologist, intensivist and research chief of Pulmonary, Critical Care and Sleep Medicine and internationally recognized expert in sleep apnea. He is active clinically in pulmonary, critical care and sleep medicine. In the sleep clinic, Malhotra provides a full spectrum of diagnostic and therapeutic services to patients with sleep-related disorders, including insomnia, restless leg syndrome, narcolepsy and sleep disorders associated with psychiatric conditions.
A professor in the Department of Medicine at University of California San Diego School of Medicine, Malhotra is involved in training medical students, residents and fellows.
He was president of the American Thoracic Society (2015-2016), has taught and presented his research on sleep-related disorders locally, regionally, nationally and internationally and has published more than 310 original manuscripts in leading journals, plus 220 reviews and chapters. He is a principal- and co-investigator on numerous National Institutes of Health (NIH) grants relating to sleep apnea and serves as an ad hoc reviewer for many leading journals, including the New England Journal of Medicine, Mayo Clinic Proceedings, Sleep and the Journal of American Medical Association. To view a full list of his publications, visit PubMed.
Before joining UC San Diego Health, Malhotra practiced pulmonary, critical care and sleep medicine at Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Brigham and Women's Hospital. He also served as attending physician in intensive care at King Faisal Hospital in Rwanda. He was associate professor at Harvard Medical School and medical director of the Brigham and Women's Hospital Sleep Disorders Research Program.
Malhotra completed his fellowship training in pulmonary and critical care medicine at Harvard Medical School and a residency in internal medicine at the Mayo Clinic. He completed an internship at St. Thomas Medical Center in Akron, OH and received his medical degree from the University of Alberta in Canada.